Devonian Health Group is trading 11.94% up at CA$7.50 on October 8, 2026, with no clear company-specific catalyst identified. - The latest surfaced company news was a September announcement of an NYSE American listing plan, not a new October 8 catalyst. - Supplied market context showed major U.S. indices modestly lower; Wednesday’s reported declines were broader and in the opposite direction, leaving the move’s specific cause unclear.